Abstract: The goal of this paper is to establish an analysis and prediction model of bioengineering experimental data combining big data and deep learning (DL), so as to improve the analysis ...
New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel, Switzerland Part ...
Part of a USD 23 billion US investment to expand R&D and advanced manufacturing to reach more patients East Hanover, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global ...
How does origami-like DNA affect brain development? How do cancer-immune cell interactions prevent immune cell activity in tumors? Two breakthrough discoveries by UC San Francisco scientists answer ...
Abstract: We present a geometry-driven graph learning framework for histopathology that converts Tissue Microarray (TMA) images into Delaunay triangulation graphs of superpixels. Unlike ...
Add Yahoo as a preferred source to see more of our stories on Google. After hitting the market Jan. 16 for nearly $6.3 million, a sprawling New Mexico estate that was long home to two-time ...
Eli Lilly & Co. struck a deal worth more than $1.1 billion with German biotech Seamless Therapeutics GmbH to develop gene therapies for hearing loss. Closely-held Seamless will design a type of enzyme ...
Eli Lilly is continuing a run of dealmaking to strengthen its genetic medicine offering by penning a pact with gene editing company Seamless Therapeutics. This morning’s deal with Seamless centers on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results